Nanovibronix Stock Analysis

NanoVibronix Stock Analysis Notes

The company has price-to-book ratio of 1.88. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NanoVibronix recorded a loss per share of 13.53. The entity had not issued any dividends in recent years. The firm had 1:11 split on the 14th of March 2025. NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York. Nanovibronix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To find out more about NanoVibronix contact Brian Murphy at 914 233 3004 or learn more at https://www.nanovibronix.com.

NanoVibronix Investment Alerts

NanoVibronix Upcoming and Recent Events

NanoVibronix Largest EPS Surprises

View All Earnings Estimates

NanoVibronix Environmental, Social, and Governance (ESG) Scores

NanoVibronix Thematic Classifications

NanoVibronix Stock Institutional Investors

Note, although NanoVibronix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

NanoVibronix Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.53 M.

NanoVibronix Profitablity

The company has Profit Margin (PM) of (0.94) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.58) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.58.

Management Efficiency

NanoVibronix has return on total asset (ROA) of (0.2651) % which means that it has lost $0.2651 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9409) %, meaning that it created substantial loss on money invested by shareholders. NanoVibronix's management efficiency ratios could be used to measure how well NanoVibronix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.53 in 2025. Return On Capital Employed is likely to climb to -0.89 in 2025. At this time, NanoVibronix's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 228.2 K in 2025, whereas Return On Tangible Assets are likely to drop (0.53) in 2025.

Technical Drivers

As of the 21st of March, NanoVibronix secures the Downside Deviation of 8.57, mean deviation of 8.03, and Risk Adjusted Performance of 0.0189. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NanoVibronix, as well as the relationship between them. Please verify NanoVibronix standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if NanoVibronix is priced some-what accurately, providing market reflects its recent price of 4.39 per share. Given that NanoVibronix has jensen alpha of 0.2157, we recommend you to check NanoVibronix's last-minute market performance to make sure the company can sustain itself at a future point.

NanoVibronix Price Movement Analysis

NanoVibronix Insider Trading Activities

NanoVibronix Outstanding Bonds

NanoVibronix Predictive Daily Indicators

NanoVibronix Corporate Filings

NanoVibronix Forecast Models

NanoVibronix's time-series forecasting models are one of many NanoVibronix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NanoVibronix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how NanoVibronix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NanoVibronix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NanoVibronix. By using and applying NanoVibronix Stock analysis, traders can create a robust methodology for identifying NanoVibronix entry and exit points for their positions.

When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.